Ca2+ mishandling in heart failure: Potential targets

Ca2+ mishandling is a common feature in several cardiovascular diseases such as heart failure (HF). In many cases, impairment of key players in intracellular Ca2+ homeostasis has been identified as the underlying mechanism of cardiac dysfunction and cardiac arrhythmias associated with HF. In this re...

Descripción completa

Detalles Bibliográficos
Autores: Val-Blasco, Almudena, Gil-Fernández, Marta, Rueda, Angélica, Pereira, Laetitia, Delgado, Carmen, Smani, Tarik, Ruiz-Hurtado, Gema, Fernández-Velasco, María
Tipo de recurso: artículo
Estado:Versión aceptada para publicación
Fecha de publicación:2021
País:España
Institución:Consejo Superior de Investigaciones Científicas (CSIC)
Repositorio:DIGITAL.CSIC. Repositorio Institucional del CSIC
OAI Identifier:oai:digital.csic.es:10261/264859
Acceso en línea:http://hdl.handle.net/10261/264859
Access Level:acceso abierto
Palabra clave:Calcium handling
EC coupling
Heart failure
Ryanodine
Descripción
Sumario:Ca2+ mishandling is a common feature in several cardiovascular diseases such as heart failure (HF). In many cases, impairment of key players in intracellular Ca2+ homeostasis has been identified as the underlying mechanism of cardiac dysfunction and cardiac arrhythmias associated with HF. In this review, we summarize primary novel findings related to Ca2+ mishandling in HF progression. HF research has increasingly focused on the identification of new targets and the contribution of their role in Ca2+ handling to the progression of the disease. Recent research studies have identified potential targets in three major emerging areas implicated in regulation of Ca2+ handling: the innate immune system, bone metabolism factors and post-translational modification of key proteins involved in regulation of Ca2+ handling. Here, we describe their possible contributions to the progression of HF.